Deleting one gene "may completely prevent pancreatic cancer"

Deleting one gene

PanARMENIAN.Net - Using a mouse model of pancreatic cancer, researchers have zoomed in on a single gene that stopped aggressive pancreatic cancer from developing when the scientists removed it, medical News Today says.

Pancreatic cancer is an aggressive form of cancer that tends to be diagnosed quite late and often resists treatment.

According to the National Cancer Institute (NCI), pancreatic cancer is the fourth leading cause of cancer death in the United States. Some estimates predict that by 2020, pancreatic cancer will become the second leading cause of death.

The NCI estimate that in 2019 there will be 56,770 new cases of pancreatic cancer and 45,750 deaths resulting from it.

One of the main drivers behind pancreatic cancer is the so-called KRAS oncogene. But new research identifies another gene whose action is crucial for the development of this cancer.

Dr. Diane Simeone, who is the director of the Pancreatic Cancer Center at the New York University Langone Health's Perlmutter Cancer Center, is the corresponding author of this new research.

Dr. Simeone and her colleagues carried out a study in mice and human patient samples to examine the role of a gene called "ataxia-telangiectasia group D complementing" (ATDC) in pancreatic tumor formation.

The researchers will be publishing their findings in the journal Genes & Development.

 Top stories
Authorities said a total of 192 Azerbaijani troops were killed and 511 were wounded during Azerbaijan’s offensive.
In 2023, the Azerbaijani government will increase the country’s defense budget by more than 1.1 billion manats ($650 million).
The bill, published on Monday, is designed to "eliminate the shortcomings of an unreasonably broad interpretation of the key concept of "compatriot".
The earthquake caused a temporary blackout, damaged many buildings and closed a number of rural roads.
Partner news